Tilray Brands, Inc. Deferred Income Tax Expense (Benefit)
Tilray Brands, Inc. (TLRY) reported Deferred Income Tax Expense (Benefit) of $8.02 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-07-28
- Tilray Brands, Inc. deferred income tax expense (benefit) for the quarter ending 2023-05-31 was -$4.10M.
- Tilray Brands, Inc. deferred income tax expense (benefit) for the quarter ending 2023-02-28 was -$16.60M.
- Tilray Brands, Inc. deferred income tax expense (benefit) for the quarter ending 2022-11-30 was -$13.74M, a 200.67% decline year-over-year.
- Tilray Brands, Inc. deferred income tax expense (benefit) for the quarter ending 2022-08-31 was $796.00K.
- Tilray Brands, Inc. deferred income tax expense (benefit) for fiscal 2026 was $8.02M.
- Tilray Brands, Inc. deferred income tax expense (benefit) for fiscal 2025 was -$125.51M.
- Tilray Brands, Inc. deferred income tax expense (benefit) for fiscal 2024 was -$38.87M.
- Tilray Brands, Inc. deferred income tax expense (benefit) for fiscal 2023 was -$33.63M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-05-31 | $8.02M 10-K · filed 2026-07-28 | ||||
| 2025-05-31 | -$125.51M 10-K · filed 2026-07-28 | ||||
| 2024-05-31 | -$38.87M 10-K · filed 2026-07-28 | ||||
| 2023-05-31 | -$4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | -$20.69M derived: sum of 2 quarters · filed 2025-07-29 | -$34.43M derived: sum of 3 quarters · filed 2025-07-29 | -$33.63M 10-K · filed 2025-07-29 | |
| 2023-02-28 | -$16.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | -$30.33M derived: sum of 2 quarters · filed 2023-04-10 | -$29.54M 10-Q · filed 2023-04-10 | -$42.79M derived: sum of 4 quarters · filed 2024-07-30 | |
| 2022-11-30 | -$13.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | -$12.94M 10-Q · filed 2023-01-09 | -$26.20M derived: sum of 3 quarters · filed 2024-07-30 | -$32.26M derived: sum of 4 quarters · filed 2024-07-30 | |
| 2022-08-31 | $796.00K 10-Q · filed 2022-10-07 | -$12.46M derived: sum of 2 quarters · filed 2024-07-30 | -$18.53M derived: sum of 3 quarters · filed 2024-07-30 | -$4.88M derived: sum of 4 quarters · filed 2024-07-30 | |
| 2022-05-31 | -$13.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | -$19.32M derived: sum of 2 quarters · filed 2024-07-30 | -$5.68M derived: sum of 3 quarters · filed 2024-07-30 | -$30.55M 10-K · filed 2024-07-30 | -$27.54M 10-K · filed 2022-07-28 |
| 2022-02-28 | -$6.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | $7.58M derived: sum of 2 quarters · filed 2023-04-10 | -$17.30M 10-Q · filed 2023-04-10 | -$6.75M derived: sum of 4 quarters · filed 2023-07-26 | |
| 2021-11-30 | $13.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | -$11.23M 10-Q · filed 2023-01-09 | -$680.00K derived: sum of 3 quarters · filed 2023-07-26 | ||
| 2021-08-31 | -$24.87M 10-Q · filed 2022-10-07 | -$14.32M derived: sum of 2 quarters · filed 2023-07-26 | |||
| 2021-05-31 | $10.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | -$24.90M 10-K · filed 2023-07-26 | -$24.87M 10-K · filed 2021-07-28 | ||
| 2021-03-31 | -$635.00K 10-Q · filed 2021-05-10 | ||||
| 2021-02-28 | $731.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-06 | -$35.44M 10-Q · filed 2022-04-06 | |||
| 2020-12-31 | -$1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | -$5.38M 10-K · filed 2021-02-19 | |||
| 2020-11-30 | -$18.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-10 | -$36.17M 10-Q · filed 2022-01-10 | |||
| 2020-09-30 | $134.00K 10-Q · filed 2020-11-09 | -$4.01M 10-Q · filed 2020-11-09 | |||
| 2020-08-31 | -$17.98M 10-Q · filed 2021-10-07 | ||||
| 2020-06-30 | -$2.88M 10-Q · filed 2020-08-10 | -$4.15M 10-Q · filed 2020-08-10 | -$9.01M derived: sum of 3 quarters · filed 2021-05-10 | -$6.58M derived: sum of 4 quarters · filed 2021-05-10 | |
| 2020-05-31 | -$13.30M 10-K · filed 2022-07-28 | ||||
| 2020-03-31 | -$1.27M 10-Q · filed 2021-05-10 | -$6.13M derived: sum of 2 quarters · filed 2021-05-10 | -$3.70M derived: sum of 3 quarters · filed 2021-05-10 | -$6.34M derived: sum of 4 quarters · filed 2021-05-10 | |
| 2019-12-31 | -$4.86M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | -$2.43M derived: sum of 2 quarters · filed 2021-02-19 | -$5.07M derived: sum of 3 quarters · filed 2021-02-19 | -$8.85M 10-K · filed 2021-02-19 | |
| 2019-09-30 | $2.43M 10-Q · filed 2020-11-09 | -$210.00K derived: sum of 2 quarters · filed 2020-11-09 | -$3.99M 10-Q · filed 2020-11-09 | -$8.56M derived: sum of 4 quarters · filed 2021-02-19 | |
| 2019-06-30 | -$2.64M 10-Q · filed 2020-08-10 | -$6.42M 10-Q · filed 2020-08-10 | -$10.99M derived: sum of 3 quarters · filed 2021-02-19 | -$10.97M derived: sum of 4 quarters · filed 2021-02-19 | |
| 2019-05-31 | -$5.83M 10-K · filed 2021-07-28 | ||||
| 2019-03-31 | -$3.78M 10-Q · filed 2020-05-11 | -$8.35M derived: sum of 2 quarters · filed 2021-02-19 | -$8.32M derived: sum of 3 quarters · filed 2021-02-19 | ||
| 2018-12-31 | -$4.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | -$4.55M derived: sum of 2 quarters · filed 2021-02-19 | -$4.49M 10-K · filed 2021-02-19 | ||
| 2018-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $87.00K 10-Q · filed 2018-11-14 | |||
| 2018-06-30 | $63.00K 10-Q · filed 2018-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |